at your finger tips
in concise, plain language
Legislation watch

2014 House Bill 5598: Authorize “biosimilar" dru substitutions
  1. Introduced by Rep. Ken Yonker (R) on May 27, 2014, to permit a pharmacist to substitute FDA-designated biosimilar drugs for brand-name drugs.   Full Text and Analysis.
    • Referred to the House Health Policy Committee on May 27, 2014.

Comments